Skip to content

    Recently Viewed

      Listening...

      Home / Our Company / Our societal impact / Global Health Equity /
      What is your hope for a future with drug-resistant TB?
      Paul Thorn, DR-TB survivor, speaking on camera during segment on efforts to combat the threat of drug-resistant tuberculosis

      What is your hope for a future with drug-resistant TB?

      Share Article
      share to

      Delay is no longer an option — it’s time to step up the fight to end drug-resistant TB. A new report published by The Economist Intelligence Unit (EIU), and with support from Johnson & Johnson, emphasizes the urgent need for focused global action to address the growing threat of DR-T

      Learn more about the report here.

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.